Skip to main content
. 2023 Aug 21;14(4):312–320. doi: 10.24171/j.phrp.2023.0069

Table 2.

Frequency of interventions recommended to control CPE outbreaks in healthcare settings based on epidemiological investigations, as reported to the KDCA from June 2017–September 2022

Characteristic Total (n=168) Tertiary general hospital (n=27) General hospital (n=92) Hospital (n=19) Intermediate care hospital (n=30) p a)
Type of recommended interventions
 Education of employees, including caregivers 64 (38.1) 12 (44.4) 34 (37.0) 10 (52.6) 8 (26.7) 0.28
 Active surveillance of high-risk groups 55 (32.7) 11 (40.7) 34 (37.0) 3 (15.8) 7 (23.3) 0.17
 Contact precautions 53 (31.5) 11 (40.7) 27 (29.3) 7 (36.8) 8 (26.7) 0.60
 Environmental cleaning 51 (30.4) 5 (18.5) 23 (25.0) 13 (68.4) 10 (33.3) <0.01
 Screening contacts of patients with CRE 49 (29.2) 5 (18.5) 30 (32.6) 7 (36.8) 7 (23.3) 0.40
 Patient isolation or cohorting 40 (23.8) 9 (33.3) 16 (17.4) 3 (15.8) 12 (40.0) 0.04
 Support for staff and infrastructure 22 (13.1) 2 (7.4) 12 (13.0) 4 (21.1) 4 (13.3) 0.60
 Surveillance of environmental cultures 20 (11.9) 2 (7.4) 10 (10.9) 0 (0) 8 (26.7) 0.03
 On-site monitoring 15 (8.9) 3 (11.1) 6 (6.5) 4 (21.1) 2 (6.7) 0.21
 Improvement of bed density 13 (7.7) 2 (7.4) 7 (7.6) 3 (15.8) 1 (3.3) 0.48
 Timely notification of CRE to KDCA 6 (3.6) 1 (3.7) 1 (1.1) 0 (0) 4 (13.3) 0.02
 Antibiotic stewardship 4 (2.4) 0 (0) 4 (4.3) 0 (0) 0 (0) 0.67
No. of intervention types recommended for each outbreak
 0 (None of the above) 22 (13.1) 3 (11.1) 15 (16.3) 1 (5.3) 3 (10.0) 0.63
 1–2 70 (41.7) 12 (44.4) 39 (42.4) 8 (42.1) 11 (36.7) 0.94
 3–7 76 (45.2) 12 (44.4) 38 (41.3) 10 (52.6) 16 (53.3) 0.61

Data are presented as the no. of outbreaks (%) (multiple selections available).

CPE, carbapenemase-producing Enterobacteriaceae; KDCA, Korea Disease Control and Prevention Agency; CRE, carbapenem-resistant Enterobacteriaceae.

a)

Generated using the Fisher exact test.